BioCentury

INTRODUCTION

Letter from the Editor

PART 1

Imperative of COVID

PART 2

Addressing disparities

PART 3

Data sharing

PART 4

Master protocols

PART 5

Pandemic preparedness

ARTICLE | Product Development

Governments must work alongside industry to fill the cracks exposed by COVID-19 before the next, inevitable, pandemic

When next crisis hits, the world should be able to turn to a stockpile of countermeasures and an efficient system for manufacturing, distributing them

By Steve usdin, washington editor, and c. simone fishburn, Editor in chief
September 11, 2020 2:18 AM UTC

This is the fifth and final article in BioCentury’s 28th Annual Back to School package. In the opening piece, BioCentury called on biopharma to convert its COVID response to a new era of efficient drug development and address the urgent healthcare chasms exposed by the crisis.

As bad as COVID-19 has been, the next pandemic — and there will be more — could be far worse unless societies step up to the challenge by investing in drug, vaccine and diagnostics R&D, surge manufacturing capacity, and early warning disease surveillance systems. ...